1 year return (CAGR)
30.35%
CureVac NV Exchange (NASDAQ, USD)
CVAC
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-8.78%
5 year return (CAGR)
-44.03%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.05B
Price/Sales
2.06
Ent value
900.60M
Price/Book
1.20
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
5.42
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 4.66 |
| Daily high | 4.66 |
| Daily low | 4.66 |
| Daily Volume | 0K |
| 1y analyst estimate | 5.40 |
| Beta | 1.77 |
| EPS (TTM) | 0.86 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 29 Apr 2026 |
Downside potential
Loading...
Downside potential data
| CVAC | S&P500 | |
| Current price drop from All-time high | -96.58% | -1.04% |
| Highest price drop | -98.30% | -56.47% |
| Date of highest drop | 25 Apr 2024 | 9 Mar 2009 |
| Avg drop from high | -80.41% | -10.68% |
| Avg time to new high | 151 days | 12 days |
| Max time to new high | 1274 days | 1805 days |
News
No items found